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Structure of mammalian ornithine decarboxylase at 1.6 Å
resolution: stereochemical implications of PLP-dependent amino
acid decarboxylases
Andrew D Kern1, Marcos A Oliveira1, Philip Coffino2 and Marvin L Hackert1*
Background: Pyridoxal-5′-phosphate (PLP) dependent enzymes catalyze a
broad range of reactions, resulting in bond cleavage at Cα, Cβ, or Cγ carbons
of D and L amino acid substrates. Ornithine decarboxylase (ODC) is a
PLP-dependent enzyme that controls a critical step in the biosynthesis of
polyamines, small organic polycations whose controlled levels are essential for
proper growth. ODC inhibition has applications for the treatment of certain
cancers and parasitic ailments such as African sleeping sickness.
Results: The structure of truncated mouse ODC (mODC′) was determined by
multiple isomorphous replacement methods and refined to 1.6 Å resolution.
This is the first structure of a Group IV decarboxylase. The monomer contains
two domains: an α/β barrel that binds the cofactor, and a second domain
consisting mostly of β structure. Only the dimer is catalytically active, as the
active sites are constructed of residues from both monomers. The interactions
stabilizing the dimer shed light on its regulation by antizyme. The overall
structure and the environment of the cofactor are compared with those of
alanine racemase.
Conclusions: The analysis of the mODC′ structure and its comparison with
alanine racemase, together with modeling studies of the external aldimine
intermediate, provide insight into the stereochemical characteristics of
PLP-dependent decarboxylation. The structure comparison reveals
stereochemical differences with other PLP-dependent enzymes and the
bacterial ODC. These characteristics may be exploited in the design of new
inhibitors specific for eukaryotic and bacterial ODCs, and provide the basis for
a detailed understanding of the mechanism by which these enzymes regulate
reaction specificity.
Introduction
Pyridoxal-5′-phosphate (PLP) and pyridoxamine 5′-phos-
phate (PMP) are enzyme cofactors utilized extensively in
amino acid metabolism [1]. The structure and evolution of
vitamin B6 dependent enzymes has recently been
reviewed by Jansonius [2]. The B6-dependent family of
enzymes is described by four fold types represented by
asparate amino transferase [3] (fold-type I), tryptophan
synthase β subunit [4] (fold-type II), alanine racemase [5]
(fold-type III), and D-amino acid aminotransferase [6]
(fold-type IV). These holoenzymes all contain an internal
aldimine where the PLP is bound to an active-site lysine
via a Schiff-base linkage. The amino acid substrate reacts
with the cofactor via a transaldimination reaction to form
an external aldimine. Any one of three remaining bonds
around the Cα carbon may be cleaved, enabling a broad
range of reactions including transamination, racemization,
retro-aldo cleavage, deamination, decarboxylation and
replacement reactions [1]. This versatility of the PLP
cofactor is demonstrated by its incorporation into at least
four distinct protein folds of widely varying polypeptide
lengths, oligomeric forms, and with variable stabilities
[2–14]. According to the Dunathan hypothesis [15], the
sigma bond to be cleaved is oriented perpendicular to the
plane of the pyridine ring in order to maximize overlap
with the pi system of conjugated double bonds, thereby
stabilizing the negative charge generated upon bond
cleavage. PLP-dependent enzymes achieve reaction
specificity by positioning specific ‘subsites’ that interact
with each of the groups surrounding the Cα carbon of the
substrate in a geometry that favors a particular bond cleav-
age. In decarboxylases, once the Michaelis–Menton
complex is formed, transaldimination leads to the orienta-
tion of the α carboxylate perpendicular to the pyridine
ring, followed by the release of CO2 and the formation of a
quinonoid intermediate [2]. The protonation of the
quinonoid intermediate at the Cα carbon may lead to
retention or inversion of configuration. Retention of con-
figuration is achieved when the proton donor lies on the
same side of the pyridine ring as the leaving carboxylate
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group. Inversion of configuration occurs by positioning the
proton donor on the cofactor face opposite that of the
leaving group.
Eukaryotic ornithine decarboxylase (ODC, EC 4.1.1.17) is
a PLP-dependent enzyme. As a homodimer it produces
putrescine (1,4-diaminobutane) from ornithine. This is the
first committed step in polyamine biosynthesis [16].
Polyamines are ubiquitous aliphatic amines required for
normal cell growth [17], they can be induced in response
to hormones [18,19], and they lead to apoptosis when
overabundant [20]. Constitutive ODC activity has been
observed in cancer cells [21], and its uncontrolled expres-
sion confers a cancer phenotype on some cells [22]. Con-
sequently, ODC inhibitors may be useful therapeutic
agents in the treatment of certain cancers [23] and para-
sitic diseases [24]. Difluoromethylornithine (DFMO) is
one ODC inhibitor undergoing clinical trials [25,26].
Knowledge of the different ODC folds may aid in the
design of novel, ailment-specific ODC inhibitors.
Sequence comparisons of nine PLP-dependent decar-
boxylases arrange them into four sequence groups
(Groups I–IV) [27]. However, structural comparisons
reveal only two distinct PLP-binding folds for decarboxy-
lases [28]. Groups I, II, and III share the PLP-binding
motif (fold-type I) found in the bacterial ODC from Lacto-
bacillus 30a (L30aODC) [14]. Group IV decarboxylases,
represented by mODC′ (fold-type III), includes eukary-
otic ODCs, diaminopimelate decarboxylase (DAPDC) and
biosynthetic arginine decarboxylase. Secondary structure
assignments based on comprehensive sequence compar-
isons correctly predicted that mODC′ and alanine race-
mase (ALR) would contain an α/β-barrel domain [29],
although the sheet assignments were different from those
reported here.
The expression and activity of ODC in eukaryotes is con-
trolled at many levels, including transcription, translation,
post-translational modification [30–32], and a novel mech-
anism of selective protein degradation [33]. The latter
involves a 25 kDa protein called antizyme (AZ) [34], which
exploits the rapid monomer–dimer equilibrium exhibited
by ODC [35], targeting ODC for degradation by the 26S
proteasome [33,36]. AZ is itself regulated by AZ inhibitor
[37], an enzymatically inactive protein that is homologous
to ODC, but that binds more tightly to AZ [38].
In this report we describe the crystal structure of a trun-
cated form of mouse ornithine decarboxylase (mODC′),
which contains 424 of the 461 amino acids present in the
native protein [39]. The omission of 37 C-terminal
residues prevents degradation of the enzyme; the trun-
cated protein retains catalytic activity [40]. The structure
of mODC′ is compared with that of the structurally
homologous ALR [5], which also uses PLP as a cofactor.
We present a stereochemical model for mODC′, correlat-
ing the structure with previous studies.
Results and discussion
ODC monomer is a two-domain structure
The secondary structure of the mODC′ monomer is pre-
sented schematically (Figure 1a) together with a ribbon
drawing of the monomer (Figure 1b) and an alignment of
selected sequences of Group IV decarboxylases and ALR
(Figure 1c). Each monomer is comprised of two domains,
referred to in this paper simply as the barrel domain and
the sheet domain. The crystal structure reveals that the
two domains are linked by two neighboring loops, one
preceding helix H2 and the other following H10. Residues
46–283 form an α/β barrel (the barrel domain), and the
remaining residues form a mostly β structure (the sheet
domain), which includes two sheets (S1 and S2).
The model of mODC′ starts at residue 2 leading into
β strand B1, followed by the antiparallel strand B2, then
helix H1, which has one side buried by sheet S1. The
barrel domain begins with a helix (H2) and ends with
H10, unlike most triose phosphate isomerase (TIM)
barrels which usually begin with a β strand [41]. S1 and S2
of the sheet domain twist onto one another, forming a
central hydrophobic core. S1 is made up of seven strands
(B1↑, B2↓, B18↓, B3↓, B12↑, B17↓, B14↑; arrows repre-
sent the relative orientations of the strands) whereas S2
contains four (B12↑, B13↓, B15↓, B16↑). Two small
helices (H11 and H12) cap one end of the sheet domain
and are localized at the interdomain interface (Figures 1a
and 1b). Strand B12 twists nearly 180o, connecting sheets
S1 and S2. S2 has two central strands running parallel (B13
and B15), and the outer strands (B12 and B16) run antipar-
allel to the central strands. The outer strand B16 has a
bulge of two residues.
The model presented omits highly disordered residues
(shown in cyan, Figure 1). In addition to one residue at
the N terminus and six residues at the C terminus, there
are three short disordered loops. One of these loops
(158–168) connects H7 to B8 and corresponds to a pro-
tease-sensitive loop [42]. Sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS–PAGE) analysis of
crystallized protein did not indicate proteolysis (data not
shown). The remaining disordered loops connect H1 to
B3 (30–35) and B12 to B13 (298–311). The latter loop is
localized near the active-site cavity and includes the
phosphorylation site S303 [32].
Dimer stability
Active ODC dimers are in rapid equilibrium with inactive
monomers [43]. The structure of mODC′ provides insight
into mammalian ODC dimer instability, as only 655 Å2 of
solvent-accessible surface area per monomer is buried
upon dimer formation. There is a clear separation
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between monomers within the homodimer (Figure 2). In
contrast, L30aODC dimers are very stable, involve inter-
twining of folding domains, and bury 6450 Å2 upon dimer
formation [14]. The mODC′ dimer is easily disrupted by
any mutation to G387 [44]. G387 is located between the
barrel and sheet domains (Figure 2), but is far removed
from the dimer interface, suggesting that mutations at
G387 are indirectly disrupting dimer formation, possibly
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Figure 1
Structure of mODC′. The arrangement of the
secondary structural elements of mODC′ are
depicted as a cartoon in (a) and shown as a
ribbon drawing in (b) (generated using
MOLSCRIPT [80] and Raster3D [81]). The
barrel domain is shown in yellow and sheets
S1 and S2 of the sheet domain are shown in
red and highlighted with pink and green ovals,
respectively. For mental reference, the
disordered segments (colored in cyan) have
the correct polypeptide lengths, but represent
only potential conformations. Residues
425–461, which are part of mODC but not
mODC′, are omitted entirely. The sequence
alignment of mODC′ (ODC_mus), human
ODC (ODC_hum), Trypanosomal ODC
(ODC_trp) and alanine racemase (ALR_bst) is
given in (c). The yellow, red, and cyan
underscores follow the same scheme used in
(a) and (b). The red and yellow boxes given in
(c) indicate the structurally homologous
regions, based on the structural superposition
of mODC′ and ALR. The blue boxes, shown in
the alignment (c), indicate two insertions in
ALR relative to ODC. The blue cross drawn
between residues 353 and 370 of mODC
and 303 and 316 of ALR indicate an area
where mODC′ and ALR show a topological
inversion. The secondary structural elements
of mODC′ are given above its sequence
following the nomenclature shown in (a). The
secondary structural elements of ALR,
according to [5], are given below the
sequence of ALR in (c). Conserved residues
are highlighted in bold.
by causing an alteration in angle between the barrel and
sheet domains. An example of direct disruption through
the introduction of a bulky residue has been demon-
strated by G121Y in L30aODC (R Gopal, MAO, L Zhang,
D Carroll and MLH, personal communication).
The symmetrical homodimer of mODC′ is formed by a
head-to-tail interaction between the barrel of one
monomer and the sheet domain of the second (Figure 2).
This model was proposed on the basis of site-directed
mutagenesis of active-site residues [45] and the forma-
tion of functional cross-species heterodimers [46]. Two
salt bridges (K169–D364′ and D134–K294′; primed
residues belong to the other monomer in the dimer) and
a stack of aromatic residues (F397′/Y323′/Y331 and
Y331′/Y323/F397) near the twofold axis form the primary
interactions that stabilize the dimer (Figure 2). mODC is
an obligate homodimer, and yet the size and shape of the
interface and the small number of interactions stabilizing
the dimer are very characteristic of nonobligatory com-
plexes [47]. This characteristic is consistent with the
observed rapid equilibrium [43] between mammalian
ODC monomers and dimers, which appears to be needed
for ODC regulation by AZ. AZ binds to ODC monomers
and targets them for degradation by the 26S proteasome
[33,36], but ODC dimerization apparently precludes
antizyme binding [35]. The rapid equilibrium ensures a
population of monomers, to which antizyme binds, and
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Figure 2
The mODC′ dimer. (a) A backbone worm
diagram of the mODC′ dimer viewed down
the twofold axis. One of the monomers is
colored using the same color assignments as
in Figure 1, whereas the second monomer has
its barrel domain colored in magenta and the
sheet domain in green. Key residues found at
the dimer interface are drawn in (a) and
labeled in the stereo enlargement (b). The
sheet domains near the molecular twofold axis
interact via two stacks of aromatic residues,
and salt bridges are found at the edges of the
dimer. G387, sandwiched between the barrel
and sheet domains of a monomer, is shown
colored in blue. Disordered polypeptide
segments are colored in cyan. Note the
relative locations of the cofactors at the
C-terminal ends of the α/β-barrel domain
(yellow and magenta), which open towards
the twofold axis. This figure was produced
using GRASP [82]. The twofold axis is
indicated by a black disc.
LeChatelier’s principle dictates that a depletion of the
monomer population will ultimately result in the elimi-
nation of active dimers. It has been shown that residues
117–140 (H5–H6) are necessary for AZ binding [48].
Although the electrostatic surface of mODC′ is mostly
acidic, a basic patch is found at the N-terminal end of the
barrel involving K121, K141 and R144 on helices H5 and
H6 (Figures 1 and 3). This patch is not well exposed in
the dimer, which could explain the preferential binding
of antizyme to ODC monomers. Perhaps electrostatics
will be found to play an important role in the relative
binding affinities of AZ–mODC versus AZ–AZ-inhibitor,
but a detailed analysis is beyond the scope of this paper.
Activity has been observed while expressing a circularly
permuted mODC [49], and while co-expressing two frag-
ments of Trypanosoma brucei ODC [42]. These experi-
ments suggested that the location of the domain interface
occurs around residue 305. The structure of mODC′
reveals that this is not the case and that residue 305 is
found on a disordered loop linking B12 to B13, within the
sheet domain. Active, circularly permuted protein is made
possible because of the flexibility and close spatial posi-
tion of the C and N termini in the native structure. This
enables the tethering of the N and C termini in the
inverted protein while new termini are created at a disor-
dered loop (298–311) of mODC′. The fact that the second
experiment worked is fascinating. Cutting mODC′ at
residue 305 would produce a large and a small fragment.
The large fragment would contain the entire barrel
domain, linked with B12 and the majority of S1
(Figure 1), and the smaller fragment would contain the
core portion of S2 linked with H12, B16, and H13. This
S2 fragment contains all the active-site residues from the
sheet domain, as well as most of the sheet domain’s dimer
contacts (Figure 2). The experiment strongly suggests
that this S2 fragment can retain enough of its native con-
formation so that it is still able to interact with the barrel
domain fragment to form a complete active site.
Comparison of fold with alanine racemase
A superposition of the α/β barrels of mODC′ and ALR is
shown in Figure 4a. This superposition gives a root mean
square deviation (rmsd) of 2.5 Å for the Cα carbons of 155
spatially equivalent residues (shown in yellow boxes,
Figure 1c) from each barrel. These residues account for
65% and 70% of the residues found in the barrels of
mODC′ and ALR, respectively. The equivalent residues
include the common core β structure and portions of the
helices shared by mODC′ and ALR. The dominant differ-
ence between the two barrels is found in the seventh helix
of the barrel (H9 in mODC′, Figure 4a). In mODC′ H9 is
a four-turn helix, far removed from the active site, pre-
ceded by a long loop containing a sequence fingerprint
GGG (single-letter amino acid code), which is involved in
the coordination of the PLP phosphate (Figure 4a). In
ALR this helix is only two turns in length; it is located
near the active site, is preceded and followed by short
loops, and coordinates the PLP phosphate through S204 at
its N-terminal end.
The superposition of the sheet domains (Figure 4b) gives
an rmsd of 2.0 Å for the Cα carbons of 64 residues from
each sheet (shown in red boxes, Figure 1c). This accounts
for 35% and 40% of the sheet domain residues of mODC′
and ALR, respectively. The relative (~30°) rotation of the
barrels becomes evident upon superposition of the sheet
domains. The difference in the interdomain angle is
caused by two insertions in ALR with respect to mODC′
(shown in blue boxes, Figure 1c). The first is an interdo-
main insertion (229–244) between the eighth helix of the
barrel and the ALR equivalent of mODC′ B12 (Figures 1c
and 4a). The second insertion within the sheet domain
(334–349) gives rise to a β-hairpin loop and helix, which
connect S2 and the very end of S1 in ALR (Figure 4b).
The global superposition of all spatially equivalent
residues between ALR and mODC′ (155 from the barrel
and 64 from the sheet domain of each enzyme) increases
the rmsd to 4.3 Å.
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Figure 3
Qualitative electrostatic surface potential of
the mODC′ monomer. The view in (a) shows
the dimer oriented as in Figure 2, with the
accessible surface area of the yellow–red
monomer (disordered cyan regions are not
included in the surface rendering). The view of
the dimer in (b) is perpendicular to that shown
in (a). A large electropositive patch located on
the ‘bottom’ edge of the barrel includes
residues 117–140, which have been
implicated in antizyme interaction. The color
coding is the same as in Figure 2. This figure
was produced using GRASP [82].
The amount of surface area buried upon dimer formation is
significantly different in mODC′ and ALR, most probably
a result of the interdomain-angle difference mentioned
above. In mODC′, 655 Å2 (13% of solvent-accessible
surface area) per monomer are buried upon dimer forma-
tion, whereas in ALR 948 Å2 are buried (19% of solvent-
accessible area) per monomer. The relatively smaller
amount of buried surface area in mODC′ is consistent with
the observation of easily dissociable mODC dimers, which
appear to be necessary for the regulation of mODC by AZ
as described earlier.
Two other differences between mODC′ and ALR are
worth mentioning. The first is an interesting topological
inversion (indicated by the crossed, blue lines in Figure 1c).
This strand is found to contain active-site residues in each
enzyme (C360′, D361′ in mODC′; C311′, D313′ in ALR)
and occupies roughly the same space, and yet the direction-
ality of the chain is reversed between the enzymes. The
second difference pertains to a mobile loop that is disor-
dered in the mODC′ structure, but ordered in ALR. In
mODC′ the disordered loop is found between strands B12
and B13, and it contains a potential phosphorylation site,
S303 [32]. In ALR the loop contributes an important active
site residue, Y265′ [5].
Active site of mODC′
The PLP cofactor is bound via a Schiff base on the C-ter-
minal end of the α/β barrel in a manner similar to that
observed for other cofactors utilizing this fold. The active
site is localized in a shallow cavity at the subunit interface
(Figures 2 and 3). It is formed primarily from residues
donated by loops from the C-terminal end of the
α/β-barrel domain, one loop from the sheet domain (con-
necting B14 and B15 of S2) and two additional loops
(357′–364′, 398′–403′) from the sheet domain of the
second monomer. One of the salt bridges (K169–D364′)
that stabilizes the dimer fixes the loop containing
residues C360′, D361′ and D364′ from the neighboring
monomer to complete the active site (Figure 2). This is in
agreement with the observed loss of activity when K169
is mutated [50].
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Figure 4
Structural comparison of mODC′ and ALR
(PDB accession code 1SFT). Comparison of
mODC′ (purple) and ALR (green) based on
the superposition of the α/β barrels is
illustrated in (a), with their respective sheet
domains shown in faded colors. The
comparison of the two structures based on
the superposition of the sheet domains is
shown in (b), using dimmed colors for the
barrel domains. Notice in (b) how the
superposition of the sheet domains enhances
the difference in the angle between the barrel
and sheet domains of the two structures
(~30°). The cofactor is shown as a stick
model in both (a) and (b). The unique portions
of ALR are shown in blue whereas the
corresponding regions in mODC′ are shown
in cyan. This figure was produced using
GRASP [82].
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Figure 5
Active site of mODC′ and comparison with
ALR. (a) Schematic drawing of the mODC′
active site illustrating the hydrogen-bond
interactions. Residues shown in bold face are
nearer the viewer. (b) Stereo figure of the
active site of mODC′ with electron density
superimposed with its model. K69 of mODC′
is in Schiff-base linkage to the cofactor, E274
pairs with the pyridine ring nitrogen N1, and
H197 stacks on the si face of the cofactor
ring. Note the angle between K69 and the
pyridine ring of the cofactor exposing the si
face. The map is a 2Fo–Fc map at 1.6 Å
resolution contoured at 1.2σ. (c) A view of the
ALR and mODC′ active sites resulting from
the superposition of their cofactor rings. The
mODC′ active site is depicted in light gray.
The figures were generated using
BOBSCRIPT [83], MOLSCRIPT [80] and
Raster3D [81].
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Structure
The position and orientation of the cofactor in the active
site is governed primarily by protein interactions with the
5′-phosphate and the pyridine nitrogen, N1 (Figure 5a,b).
The phosphate binds in a pocket formed by two loops
(235–241, 274–276) and the N terminus of H10. One of
these loops contains the GGG sequence (residues
235–237), which is conserved in all Group IV PLP-depen-
dent decarboxylases, and the other loop connects B11 to
H10. Both loops contribute hydrogen bonds involving
mainchain nitrogens (G237, G276, R277). R277, at the N
terminus of H10, contributes a hydrogen bond to the
phosphate via its Nε, while the Nε nitrogens are held in
place by a salt bridge to D332. This salt bridge restrains
R277 while interconnecting the barrel and sheet domains.
Studies of an R277A mutant, at the optimal pH (8.0),
shows a ~100-fold decrease in PLP binding as well as a
50% drop in kcat and a ~sevenfold decrease in KM [51].
The 5′ phosphate is further fixed by a hydrogen bond to
Y389 (Figure 5a,b). Interestingly, a similar tyrosine is
found with the same geometry in aspartate aminotrans-
ferase [3], the fold of which more closely resembles that of
the bacterial L30aODC [14]. A tightly bound water mol-
ecule (HOH 744), interacting with a carbonyl (F238) and a
mainchain nitrogen (Y278), is found buried beneath the
phosphate, hydrogen-bonded to O3P. The primary inter-
action of N1–PLP is with E274 [52]. It is part of a cluster
of acidic residues (D88, E274, D233) that, with three
bound water molecules (Figure 5b), form a network of
hydrogen bonds that probably influences the electron-
withdrawing properties of the cofactor.
The extensive number of interactions between mODC′
and the 5′ phosphate is consistent with the PLP binding
constant observed for trypanosomal ODC (KD < 0.05 µM
at optimal pH of 8.0, [51]). Characterizations of native
mODC′ and the R277A mutant using 31P nuclear mag-
netic resonance (NMR) spectroscopy suggest that the
phosphate is bound in a strained conformation relative to
other PLP-dependent enzymes. The active site of
mODC′ is highly hydrophilic and shows a number of
ordered waters. This is in contrast to other PLP enzymes
(i.e. ALR, L-Aspartate amino transferase (L-AspAT),
L30aODC, and tryptophan synthase), where one face of
the cofactor is usually buried against a hydrophobic
surface [5,3,4,14]. Thus, in order to have a better control
over catalytic intermediates that are linked to PLP it is
important to fix the phosphate tightly.
The environment of the pyridine ring and its other sub-
stituents (Figure 5a,b) also affects enzyme activity [53].
The methyl group, commonly found in a hydrophobic
environment, is observed in a hydrophilic environment
generated by R154, E274, and bound solvent molecules.
The hydroxyl group is within hydrogen-bonding distance
(3.1 Å) of the backbone carbonyl of C360′, which is also
3.0 Å from the aldimine nitrogen atom of the pyridine ring
(Figure 5), suggesting that the carbonyl of C360′ could be
involved in stabilization of the quinonoid intermediate.
This scenario is in sharp contrast to L30aODC, where the
aldimine nitrogen is hydrogen-bonded to the hydroxyl
group of the pyridine ring and is found in the plane of the
pyridine ring [14].
Comparison with the ALR active site
Comparison of the structures of mODC′ with ALR reveals
that residues governing cofactor binding are more con-
served than those that determine the catalytic potential
and the stereospecificity of the reaction. The phosphate
and N1 nitrogen act as pivot points, anchoring the cofactor
as it swings between internal and external aldimine forms
during a catalytic cycle. Superposition optimized on just
the two cofactor rings results in an increase of the rms fit
of the selected barrel residues from 2.5 Å to 7.5 Å, indicat-
ing that the two cofactors do not sit identically within their
respective barrels. However, overlapping the two cofactors
is an excellent way of viewing the cofactor environments
in the two enzymes (Figure 5c).
The comparison of the phosphate environment shows
significant similarity with Y389 of mODC′ closely over-
lapping Y43 of ALR. Both tyrosines form hydrogen bonds
to O1P of the cofactor. A comparison of the cofactor
hydrogen bonds in the two active sites is shown in
Table 1. It can be seen that both enzymes immobilize
the cofactor phosphate using backbone nitrogens. The
backbone nitrogens of G276, R277, and G237 in mODC′
are equivalent to G221, I222, and S204 in ALR. The
sidechain of S204 in ALR also provides a hydrogen bond
to O3P, which is replaced by a water molecule in
mODC′. The sidechain interaction of R277 with the
phosphate in mODC′ is replaced by Y354 in ALR. The
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Table 1
Comparison of the protein interactions with pyridoxal-5′-
phosphate linked to ALR and mODC′*.
Cofactor atoms mODC′ (distances in Å) ALR (distances in Å)
PLP/LYS NZ HOH 688  O  3.2 no equivalent
C360′ O 3.0 no equivalent
PLP N1 E274  OE1  2.7 R219 NE  2.7
PLP O3 HOH 686 O  2.5 HOH 711′ O 2.8
no equivalent R136  NH2  3.1
C360′ O  3.1 no equivalent
no equivalent acetate  OXT  3.2
PLP O1P Y389  OH  2.5 Y43  OH  2.7
R277     N  2.8 I222  N 2.8
PLP O2P R277  NE  2.9 Y354  OH  2.9
HOH 724  O  2.5 HOH 563  O  2.7
no equivalent HOH 547  O  3.0
PLP O3P HOH 744  O  2.7 S204  OG  2.7
G237  N  2.9 S204 N  3.0
G276  N  3.0 G221  N  3.2
*See Figure 7.
arginine in mODC′ would be expected to provide much
tighter binding.
There is a striking difference in the environments around
N1 in both structures. In most PLP-dependent enzymes,
an acidic group (E274 in the case of mODC′) is usually
found to interact with the pyridine nitrogen (N1), whereas
in ALR the group (R292, [5]) is basic. The basic environ-
ment around N1 in ALR has two potential effects, as sug-
gested by Shaw et al. [5]. The first effect is a decrease in
the pKa of the N1 nitrogen, keeping it less protonated,
and diminishing its electron-withdrawing capabilities rela-
tive to mODC′. R292 will also affect the protonation state
of the imine nitrogen, influencing the efficiency of the
transaldimination step of ALR. In contrast, in mODC′ the
presence of three acidic groups (D88, D233, and E274)
near the N1 nitrogen probably enhances activity by
increasing the pKa of N1. This view is consistent with
data suggesting that the pKa of N1 is 8.5 [51], and that the
slowest step in the reaction of the trypanosomal ODC is
product release [54].
In mODC′, both faces of the pyridine ring (re and si,
Figure 5a) are surrounded by hydrophilic residues, even
the buried re side faces a small hydrophilic cavity; whereas
in ALR the buried re face is in a tight, hydrophobic envi-
ronment. The cofactor methyl group of mODC′ is in a
hydrophilic environment, near R154, whereas in ALR the
methyl is near the hydrophobic regions of Y164 and L85.
Interactions surrounding the pyridine hydroxyl affect the
pKa of the imine nitrogen, regulating the efficiency of
transaldimination. The network of interactions involving
the pyridine hydroxyl of mODC′ probably favors the
attack by the incoming amino group of the substrate by
keeping the imine nitrogen protonated [54]. In mODC′
the pyridine hydroxyl group is within hydrogen-bonding
distance of a water (HOH 686, Figure 5b), whereas in
ALR an equivalent water (HOH 711′) bridges the
hydroxyl and an arginine (R136, Figure 5c). The main-
chain carbonyl of C360′ of mODC′ is within 3.0 Å of the
imine nitrogen, but also within 3.1 Å of the PLP O3P, and
it is potentially hydrogen-bonded to the proton shared by
those groups.
mODC′ and ALR have distinct ways of immobilizing a
histidine sidechain next to the cofactor (H197 in mODC′
and H166 in ALR). The angle between the plane of the
imidazole ring and the pyridine ring is significantly dif-
ferent in the two enzymes. The imidazole ring of H197 in
mODC′ shares a hydrogen bond via its Nε2 nitrogen with
the backbone nitrogen of G236, but its Nδ1 nitrogen is
free, allowing the plane of the imidazole ring to be within
10° of stacking parallel against the pyridine ring. In con-
trast, H166 of ALR requires a rotation of 35° to make
these rings parallel. In ALR the two rings are held even
more rigidly with respect to each other by having the
cofactor pyridine nitrogen and the sidechain of H166
both interact with the sidechain of R219. In addition, the
other side of the H166 imidazole is hydrogen-bonded to
Y265′, a residue localized in a sheet domain of a neigh-
boring monomer in the dimer. This dual interaction
essentially fixes the H166 of ALR in place, controlling
the angle of the imidazole ring with respect to the pyri-
dine ring; this  suggests a potential mechanism for tuning
the pKa of Y265′, which is thought to be a catalytic base
in the reaction of ALR [5,55].
In both mODC′ and ALR, the active site is composed in
part by a substrate-specificity loop from the sheet domain
of the neighboring monomer. This loop includes a cys-
teine and an aspartate (C360′ and D361′ in mODC′; C311′
and D313′ in ALR). The topological inversion of this loop
in mODC′ (Figure 4b) is probably related to the differ-
ences in substrate specificity of the two enzymes
(Figure 5).
Stereochemical properties
When studying the mechanisms of related enzymes it is
important to compare the chiral fidelity of their reactions.
The stereochemistry of PLP-dependent reactions involves
coenzyme face selectivity with respect to three characteris-
tics: the mode of cofactor binding, burying one of its two
faces (re or si); the orientation of the labile sigma bond per-
pendicular to the pyridine ring, positioning the cleaved
substituent on either (re or si) face; and the position of
general acid/base groups on either or both faces of the
cofactor. The stereochemical characteristics of the PLP-
dependent transaminase L-AspAT have been extensively
studied [56–63]. Transaminases use PLP or PMP for the
interconversion of keto acids and amino acids catalyzing a
stereospecific 1,3 prototropic shift whereby a proton is
abstracted from the Cα carbon and donated to the C4′
atom of the cofactor on the buried si face [56]. In ODC,
true chirality around Cα is lost when the substrate is con-
verted to putrescine; thus, any meaningful experiments in
this regard would require the use of deuterium or tritium
to determine if the Cα has undergone racemization, reten-
tion or inversion of its configuration. Unfortunately, no
such experiments have been reported for mODC.
In order to gain insight into the stereochemistry of
mODC′, we have modeled the external aldimine form of
L-α-methylornithine in the active site of mODC′. The use
of the L-α-methyl derivative of ornithine aids the visual-
ization of stereochemistry and has relevance in that the
monofluoro and difluoromethylornithines are potent
inhibitors of the enzyme. L-α-methylornithine is easily
accommodated because of the openness of that region in
the active site. There are only two ways of orienting the
carboxylate group of the substrate in the external aldimine
complex such that it is placed perpendicular to the pyri-
dine ring, satisfying the Dunathan hypothesis [15] for
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cleavage of the Cα–CO2 bond (Figure 6). In accordance
with the observation of the external aldimine form in
L-AspAT, in both models the cofactor was tilted 30° using
the phosphate and the N1 atom of pyridine as a hinge [58].
As D361′ is the primary substrate-binding determinant
[52], interactions with this residue can be used as a crite-
rion in evaluating the preferred orientation of the two
external aldimine complexes. The models (Figure 6)
suggest that the most favorable orientation of the labile
Cα–CO2 bond orients the carboxylate group on the
exposed si face of the cofactor (opposite K69 and C360′).
This positions the terminal Nε of L-α-methylornithine
only ~3.0 Å from D361′. In contrast, orienting the car-
boxylate group on the buried re face of the cofactor
(nearer K69 and C360′) positions Nε of the ornithine
sidechain away from D361′ and close to the salt bridge
D332–R277. Site-directed mutagenesis of D361A princi-
pally shows a KM effect [52], whereas mutation of K69A
results in a 561-fold reduction of kcat [64]. A mutation
similar to K69 in L-AspAT (K258A) provides evidence of
its role as an acid/base catalyst in the transaminase reac-
tion [60]. Together, these data and our modeling studies
suggest that, like DAPDC [65], decarboxylation in
mODC′ should occur with inversion of configuration
about Cα.
One notable difference between the active-sites of
mODC′ and ALR lies in the structure of an active-site
loop from the neighboring sheet domain. In ALR this loop
(259–273) is ordered and contains a proposed base (Y265′),
which interacts directly with PLP. The equivalent loop in
mODC′ (298–311) is disordered, but biochemical data
show that this loop contains a phosphorylation site (S303).
Although a conformational change of this loop upon sub-
strate binding cannot be ruled out, its acidic composition
suggests that a ‘closed’ state would lead to a more nega-
tively charged environment on the si face of the cofactor.
This should enhance removal of CO2 oriented in the si
face (Figure 6) of the cofactor and stabilize the quinonoid
intermediate. Phosphorylation of this loop would be
expected to enhance this effect. Indeed, mODC demon-
strates enhanced activity when phosphorylated at multiple
sites in vivo, but, surprisingly, phosphorylation of S303
alone has no effect on catalytic activity [31,32].
Our data are consistent with the view that PLP-dependent
enzymes having fold-type I, II, or IV [2] perform bond
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Figure 6
Models of two potential orientations of the
external aldimine form of L-α-methylornithine in
the active site of mODC′. (a) Model of the
external aldimine shown with its carboxylate
oriented towards the exposed, si, face of the
cofactor where H197 is localized. (b) Model
of the external aldimine shown with its
carboxylate pointed towards the buried re
face of PLP, on the same side as K69. Notice
how the orientation of the external aldimine
shown in (a) positions the Nε terminal amino
group of L-α-methylornithine in a more
favorable position, relative to (b), closer to the
substrate-determinant site, D361′. The
molecule depicted in gray is the cofactor
orientation as observed in the native structure.
The program SYBYL (Tripos) was used to
build and energy minimize both possibilities
into the active site of mODC′.
cleavage and proton donation/abstraction on the buried
face of the cofactor. Fold-types I and II bury the si face of
PLP whereas fold-type IV buries the re face. PLP-depen-
dent decarboxylases, classified into four sequence groups
on the basis of sequence analysis [27], fall into two struc-
tural PLP-dependent enzyme fold types [28]. Groups I, II
and III belong to fold-type I (~L-AspAT) and sequence
group IV has fold-type III (~ALR). Fold-type I decarboxy-
lases bind PLP with the si face buried along with the cat-
alytic lysine residue and possess substrate determinants
that position the carboxylate in the buried face of the
cofactor. Like its transaminase relative L-AspAT, E. coli
ODC catalyses a stereospecific reaction on the buried si
face of the cofactor [66]. Thus, decarboxylases of fold-type
I (L30aODC) should function via retention of configura-
tion about Cα. In contrast, fold III enzymes (mODC, ALR
and DAPDC) have an α/β-barrel fold, bind PLP with its si
face exposed opposite the Schiff-base lysine residue, and
may have evolved to function nonstereospecifically. This
view is supported by data obtained with racemases (ALR),
which can perform nonstereospecific transamination as a
side reaction [67], and DAPDC, where inversion of config-
uration about Cα was observed [65]. Although suggested
by this analysis, it remains to be confirmed whether or not
all fold-type III decarboxylases work with inversion of con-
figuration about Cα.
A striking example of convergent evolution is noted in the
structures of amino acid transaminases. D-amino acid
transaminase binds PLP with the si face exposed to
solvent [6] whereas in L-AspAT the re face is exposed [3].
By maintaining the relative orientations of the proton
donor and leaving groups, the site of the 1,3 prototropic
shift is kept buried, requiring a rearrangement of the sub-
strate-specificity site because of the differences in the chi-
rality of the substrate. As suggested by Grishin et al. [29],
there may still be other yet unknown PLP-binding folds,
which may increase the chemical diversity described here.
Potential proton donors
Although the identity of the proton donor in the reaction
of mODC is not yet known, there are three potential
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Figure 7
Schematic diagrams illustrating the external
aldimine forms of the cofactors in PLP-
dependent decarboxylases, transaminases,
and racemases. This cartoon shows the
relative positions of potential proton donors
with respect to the cofactor faces. mODC
and ALR have their si face exposed to
solvent, whereas L30aODC and L-AspAT
have the re face exposed. The accession
codes are: ALR (1SFT), L30aODC (1ORD)
and L-AspAT (9AAT).
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donors: two on the re face of the cofactor (K69 and C360′)
and one on the si face (H197) (Figure 7a). Alanine muta-
tions at positions K69 and C360 show a stronger kcat effect
for the K69A mutant than the C360A mutant [64]. This
implies that the proton donor involved in the reprotona-
tion of Cα is probably K69, but C360′ may serve that
purpose in the K69A mutant. Although K69 and C360′
appear to be far apart in the structure of mODC′
(SH...NH > 5 Å) (Figure 5b), a rotation of the C360′
sidechain about χ1 would put the sulfhydryl of C360′
within 3–4 Å of the K69 Nζ.
On the si face of the cofactor H197 is nearly stacked
against the pyridine ring about 4.6 Å away from the pyri-
doxal phosphate but hydrogen-bonded to the amide
nitrogen of G236. This hydrogen bond is very important
in that it connects H197 to a chain of four backbone
hydrogen-bond interactions capped by R107. Thus, H197
is an unlikely proton donor because of the higher pKa of
the arginine guanidinium with respect to the histidine
imidazole. This suggests that the primary purpose for the
hydrogen bond with G236 is to anchor the imidazole ring
of H197 in place, possibly stabilizing reaction intermedi-
ates. A similar histidine (H223) is observed in L30aODC,
where it too is found on the opposite side relative to the
lysine forming a Schiff base with PLP (Figure 7b). Stere-
ochemical studies of the bacterial ODC [66] show reten-
tion of configuration about Cα, suggesting that H223 in
L30aODC is not the proton donor, but that it probably
stabilizes PLP in its active site via base stacking of the
aromatic rings.
In the bacterial L30aODC, like in L-AspAT, the potential
bases in the reaction are found on the buried si face of the
cofactor (Figure 7b and 7d). As the proposed substrate
specificity site of L30aODC (E532) orients the carboxy-
late on the si face [12] where the potential bases are found
(Figure 7b), retention of configuration is expected, and
observed, in E. coli ODC [66]. In contrast to bacterial
ODC′s, mODC′ has the re face buried along with the
Schiff-base lysine K69 (Figure 7a).
Biological implications
Ornithine decarboxylase (ODC) is a key enzyme in
polyamine biosynthesis; polyamines are small organic
cations essential for life. ODC inhibitors may be useful
therapeutic agents in the treatment of certain cancers and
parasitic diseases. Difluoromethylornithine (DFMO) is
one ODC inhibitor undergoing clinical trials. Models of
host and parasite ODCs might aid in the design of novel,
ailment-specific inhibitors.
Cells can quickly modulate ODC activity over a large
dynamic range by altering the rate of ODC transcription
and translation, but pre-eminently by modifying the half-
life of the enzyme [68]. The present studies further our
understanding of the catalytic function of the enzyme,
confirming a series of expectations regarding the active
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Table 2
X-ray diffraction data.
Data set Resolution (Å), Completeness (%) Rmerge (%)* MIR statistics‡
redundancy (All/outer shell) (All/outer shell) (Rc/PP)
Native 1.6 / 5.0 91.3 / 75.4 8.1 / 18.8
EMTS1† 2.8 / 12.6 99.7 / 100.0 10.8 / 26.9 0.67 / 1.84
EMTS2† 2.7 / 9.6 91.5 / 92.9 5.3 / 6.4 0.59 / 2.84
K2PtCl6 2.8 / 4.5 92.0 / 88.7 4.7 / 8.1 0.92 / 0.71
K2Pt(NO2)4 2.8 / 7.0 92.7 / 97.0 4.9 / 7.4 0.85 / 1.00
†EMTS = ethymercurithiosalicylic acid. EMTS1 was collected in-house, RAXIS-4 detector (Molecular Structures Corporation), room temperature,
λ = 1.54. All other data sets were collected at CHESS, –175°C, λ = 0.918. *Rmerge(%) = 100 ×Σh(Σi|Ih,iΣ<Ih>|/ΣIh,i). The values given are those
reported by SCALEPACK. The Rcullis (RC), and phasing power (PP) values given are those reported by MLPHARE. 
Table 3
Phasing and refinement statistics.
Overall FOM (2.7 Å) before solvent flattening* 0.82
Resolution (Å) 28.0–1.6
Rfactor/Rfree† 20.0/23.4
Space group P21212 (a = 118.8 b = 74.0 c = 45.6)
No. of non-H aroms in asymmetrics unit‡
protein 3045
water 421
Average B factors (A2)
protein 21.3
water 34.0
Rms deviations§
bond lengths (Å) 0.010
bond angles (°) 2.188
dihedral angles (°) 25.478
improper angles (°) 1.949
Ramachandran plot 98% core, 2% outliers
The *figure of merit (FOM) value is that reported by MLPHARE. †Rfree
was calculated with 4% Native (1995 reflections in the Rfree set). The
values given are those reported by REFMAC. No sigma cutoff was
applied, to any of the data, for any of the statistics reported in this
table. ‡There is one monomer per asymmetric unit. Hydrogen atoms are
not included in the number of atoms. §Rms (root mean square)
deviations were produced using X-PLOR.
site that were based on studies of ODC mutants. In par-
ticular, as previously conjectured, each of the two active
sites within the enzyme homodimer lies at the subunit
interface and each contains essential elements from both
monomers. The ODC homodimer equilibrium only mod-
estly favors dimer formation. This result is consistent
with our model, which shows that only a small fraction
of monomer solvent-accessible surface area is buried
upon dimer formation. The interaction with a second
protein, antizyme (AZ), converts the ODC homodimer
to an ODC–AZ heterodimer. This has two conse-
quences: the enzyme is inactivated, because disruption of
the homodimer disassembles the catalytic site; and ODC
is degraded by the proteasome, the major neutral pro-
tease of the cell, because ODC, when associated with
AZ, is efficiently recognized and degraded by the protea-
some. The proteasome causes ODC to be destroyed and
AZ to be recycled for further use. ODC is unusual
among proteasome substrates. Almost all others require
that post-translational modification by multiple copies of
the protein ubiquitin take place before proteolysis. In
contrast, ODC forms a tight but noncovalent 1:1 stoi-
chiometric complex with AZ before degradation. The
structure of the ODC–AZ complex and its features that
specify proteasome recognition and processing remain to
be determined.
Materials and methods
Crystallization
Native conditions described here are different from those that pro-
duced crystals previously analyzed at Stanford synchrotron radiation
laboratory (SSRL) [39]. All solutions are at pH 6.5 and have 40 mM
PIPES·KOH and 0.02% (w/v) NaN3. In addition, protein solution
(PS) = 12 mgml–1 mODC′, 2.5 mM DTT, 1.0 mM EDTA; well solution
(WS) = 26% (w/v) PEG 3350; equilibrating solution (ES) = 10% (w/v)
PEG 3350; stabilizing solution (SS) = 30% (w/v) PEG 3350. Native
crystals are grown as follows: 10 µL of silica hydrogel (Hampton
Research) on a microbridge, sitting within a 3.25 ml well containing
1.0 ml ES, is gently covered with 10 µl WS. The well is sealed with
tape and equilibrated at room temperature for one week. The micro-
bridge is transferred to a well containing 1.0 ml WS. PS (20 µl) is
added to the microbridge and the well is sealed with tape. The plate is
left undisturbed in the dark at room temperature for two weeks. Crys-
tals will often be 0.5 mm in length. The microbridge is then transferred
to a well that contains 1.0 ml SS and the well sealed. If this last step is
omitted, the crystals will begin to have tattered edges and degrade.
Reproducibility varies with protein freshness and with each batch of
protein that is prepared. Crystals were taken from microbridges and
flash cooled to –175°C.
Structure determination and refinement
The ethymercurithiosalicylic acid. (MTS1) derivative (Table 2) was col-
lected both at Cornell high energy synchrotron source (CHESS) and
in-house, using an RAXIS-4 detector (Molecular Structures Corpora-
tion), room temperature, λ = 1.54 Å. All other data sets were col-
lected at CHESS F1 station using a Princeton charged-coupled
device  (CCD) detector [69], –175°C, λ = 0.918 Å. All metal deriva-
tives were soaks of crystals from the same batch used to the collect
native data set. The X-ray data were processed and merged using the
programs DENZO and SCALEPACK [70]. The program MLPHARE
[71] was used to obtain the original MIR phases. The wARP script
[72] was used to obtain a highly interpretable map. Model building
was performed using the program O [73]. X-PLOR [74], version
3.851, was used for energy minimization, torsion dynamics while
extending phases from 2.8 to 1.6 Å resolution and for picking waters.
Final refinements at 1.6 Å resolution were performed using REFMAC
[75] (Table 3). X-PLOR [74], PROCHECK [76] and WHAT_CHECK
[77] were used for structural analysis. 6D_MOLEMAN [78] was used
for structural analysis and file manipulation. Several CCP4 pro-
grams/utilities were also used [79].
Accession numbers
Coordinates have been deposited in the Brookhaven Protein Data
Bank with accession code 7ODC.
Supplementary material
Additional material is available with the internet version of this paper.
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